124 related articles for article (PubMed ID: 23037749)
1. [Immunotherapy for hematological neoplasms].
Yasukawa M
Rinsho Ketsueki; 2012 Oct; 53(10):1759-67. PubMed ID: 23037749
[No Abstract] [Full Text] [Related]
2. [WT1 peptide-based immunotherapy for the treatment of malignancies: focusing on hematological neoplasms].
Oka Y; Tsuboi A; Nishida S; Hosen N; Nakata J; Hashii Y; Maeda T; Oji Y; Kumanogoh A; Sugiyama H
Rinsho Ketsueki; 2011 May; 52(5):235-42. PubMed ID: 21646768
[No Abstract] [Full Text] [Related]
3. WT1 peptide vaccination for the treatment of hematological malignancies: the present status and future direction.
Oka Y; Tsuboi A; Shirakata T; Hosen N; Nishida S; Oji Y; Sugiyama H
Rinsho Ketsueki; 2009 May; 50(5):352-7. PubMed ID: 19483394
[No Abstract] [Full Text] [Related]
4. [NKT cell-mediated immunotherapy for hematological malignancies].
Fujii S
Rinsho Ketsueki; 2007 Mar; 48(3):188-99. PubMed ID: 17441475
[No Abstract] [Full Text] [Related]
5. [The role of interleukin-2--based immunotherapy in hematological malignancies].
Ackerstein A; Toren A; Slavin S; Nagler A
Harefuah; 1996 May; 130(9):613-7. PubMed ID: 8794642
[No Abstract] [Full Text] [Related]
6. [Cellular immunotherapy for hematological malignancies].
Yasukawa M
Rinsho Ketsueki; 2008 Oct; 49(10):1460-71. PubMed ID: 18833930
[No Abstract] [Full Text] [Related]
7. Immunomodulatory gene therapy for haematological malignancies.
Schmidt-Wolf GD; Schmidt-Wolf IG
Br J Haematol; 2002 Apr; 117(1):23-32. PubMed ID: 11918529
[No Abstract] [Full Text] [Related]
8. [The role of immunotherapy in the treatment of patients with hematologic neoplasms].
Rukavitsyn OA
Vopr Onkol; 2002; 48(2):186-92. PubMed ID: 12227066
[No Abstract] [Full Text] [Related]
9. Immunotherapy of hematological malignancies using dendritic cells.
Van de Velde AL; Berneman ZN; Van Tendeloo VF
Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412
[TBL] [Abstract][Full Text] [Related]
10. Cellular immunotherapy of cancer.
Okur FV; Brenner MK
Methods Mol Biol; 2010; 651():319-45. PubMed ID: 20686975
[TBL] [Abstract][Full Text] [Related]
11. Identification of hematological malignancy-associated antigens and clinical applications.
Fujiwara H
Rinsho Ketsueki; 2009 May; 50(5):340-51. PubMed ID: 19483393
[No Abstract] [Full Text] [Related]
12. Donor lymphocyte infusion. An adaptive cellular immunotherapy for treatment of hematological malignancies.
Owaidah TM
Saudi Med J; 2003 Feb; 24(2):138-41. PubMed ID: 12682675
[TBL] [Abstract][Full Text] [Related]
13. [Cellular immunotherapy for hematopoietic malignancies].
Yasukawa M
Nihon Rinsho; 2007 Jan; 65 Suppl 1():622-8. PubMed ID: 17476760
[No Abstract] [Full Text] [Related]
14. Immunotherapy for hematological cancer. Where are we?
Borbolla JR; López-Hernández MA
Arch Med Res; 1997; 28(4):597-8. PubMed ID: 9428591
[No Abstract] [Full Text] [Related]
15. Guest editorial: advances in immunotherapy for hematological malignancies.
Kadowaki N
Int J Hematol; 2018 Mar; 107(3):260-261. PubMed ID: 29427173
[No Abstract] [Full Text] [Related]
16. [Immunotherapy and cell therapy for myeloid leukemia].
Yasukawa M
Nihon Rinsho; 2009 Oct; 67(10):1938-43. PubMed ID: 19860194
[TBL] [Abstract][Full Text] [Related]
17. [Progress in Immunotherapy for Hematological Malignancies].
Yasukawa M
Nihon Naika Gakkai Zasshi; 2016 Jun; 105(6):1061-8. PubMed ID: 30168700
[No Abstract] [Full Text] [Related]
18. New Horizons for Immune Gene Therapy.
Barzel A; Flotte TR
Hum Gene Ther; 2019 Apr; 30(4):379-380. PubMed ID: 30950655
[No Abstract] [Full Text] [Related]
19. [Cellular immunotherapy for hematopoietic malignancies].
Yasukawa M
Nihon Rinsho; 2007 Jan; 65 Suppl 1():390-4. PubMed ID: 17474435
[No Abstract] [Full Text] [Related]
20. Dendritic cell-based tumor immunotherapy.
Kadowaki N; Kitawaki T
Rinsho Ketsueki; 2009 May; 50(5):358-63. PubMed ID: 19483395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
